A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders ...

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

March 4 () - Ozempic, Mounjaro and other GLP-1 drugs for diabetes can prevent the formation of new substance use disorders ...

Researchers at Washington University School of Medicine in St. Louis have shown in a new study that GLP-1 medications may be ...

SPONSORED: Not sure which GLP-1 is right for you? A St. Joseph Health nurse practitioner explains the key differences between Ozempic, Wegovy, Mounjaro and Zepbound — and why the distinction matters ...

Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% ...

Ziyad Al-Aly receives funding from U.S. Department of Veterans Affairs. A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his ...

Clinical trials and equitable care pathways are needed to build on early evidence of benefit Substance use disorders (SUDs) are common and burdensome for patients, families, and health systems,12 yet ...

Despite this, researchers have cautioned that if the regained weight is predominantly fat, people could "be worse off than ...

“Overall, the study reinforces that GLP-1 receptor agonists are unlikely to produce durable weight loss if used as short term interventions without longer term management plans. For many patients, ...